Based on a report by a whistleblower (Ticket #493444, June 25, 2023) about possible malpractices in ethics, we found significant similarities between the three below-mentioned articles.
1. Ghasemi A, Ghotaslou A, Mohammadi M, Abbasian S, Ghaffari K. Methylation of the Wnt Signaling Antagonist, Wnt Inhibitory Factor 1 and Dickkopf-1 Genes in Acute Myeloid Leukemia at the Time of Diagnosis. Zahedan J Res Med Sci. 2016;18(1). e5874. https://doi.org/10.17795/zjrms-5874.
Link: https://brieflands.com/articles/zjrms-5874.html
2. Ghasemi A, Ghotaslou A, Mohammadi M, Ghaffari K, Abbasian S. Dysregulation of the WNT Signaling Pathway Through Methylation of Wnt Inhibitory Factor 1 and Dickkopf-1 Genes among AML Patients at the Time of Diagnosis. Iranian Journal of Blood and Cancer. 2014;7(1):11-7.
Link: https://ijbc.ir/article-1-517-en.html
3. Ghasemi A, Mohammadi M, Ghotaslou A, Ghaffari K, Abbasian S. [Dysregulation of the Wnt Signaling Pathway through Methylation of WIF1and DKK1 Genes in Patients with Acute Myeloid Leukemia (AML) at the Time of Diagnosis]. Journal of Isfahan Medical School. 2014;32(306):1757-66. In Persian.
Link: https://jims.mui.ac.ir/article_14461.html?lang=en
Consequently, we started our investigations and collected details of explanations from all parties. Finally, the Committee of Ethics in Research and Publications in Zahedan University of Medical Sciences plus the secondary ethics committee of the publisher concluded to retract this article from our journal (Registration Number: #495916, Date: July 31, 2023) because it was already published in another journal and is a case of "republishing." Respecting our policy, it is a definite case of redundancy and double-Publication. As a result of this, we apologize to our readers for any inconvenience. The authors were already informed about this decision.
